Patient characteristics and CT response to gefitinib
| . | Patients, n (%) . | |
|---|---|---|
| Total no. patients | 28 | |
| Age, y | ||
| Median | 58 | |
| Range | 40-76 | |
| Sex | ||
| Female | 23 (82) | |
| Male | 5 (18) | |
| Histology | ||
| Adenocarcinoma only | 22 (79) | |
| Adenocarcinoma with bronchioloalveolar carcinoma features | 6 (21) | |
| Stage | ||
| IV | 28 (100) | |
| No. prior chemotherapy | ||
| 0 | 17 (61) | |
| 1 | 3 (11) | |
| 2 | 8 (28) | |
| CT response to gefitinib | ||
| Complete response | 0 (0) | |
| Partial response | 14 (50) | |
| Stable disease | 4 (14) | |
| Progressive disease | 10 (36) | |
| . | Patients, n (%) . | |
|---|---|---|
| Total no. patients | 28 | |
| Age, y | ||
| Median | 58 | |
| Range | 40-76 | |
| Sex | ||
| Female | 23 (82) | |
| Male | 5 (18) | |
| Histology | ||
| Adenocarcinoma only | 22 (79) | |
| Adenocarcinoma with bronchioloalveolar carcinoma features | 6 (21) | |
| Stage | ||
| IV | 28 (100) | |
| No. prior chemotherapy | ||
| 0 | 17 (61) | |
| 1 | 3 (11) | |
| 2 | 8 (28) | |
| CT response to gefitinib | ||
| Complete response | 0 (0) | |
| Partial response | 14 (50) | |
| Stable disease | 4 (14) | |
| Progressive disease | 10 (36) | |